Stock comparison

JPMvsLLY

JPMorgan Chase & Co vs Eli Lilly and Co. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JPM

JPMorgan Chase & Co

$310.29

-5.74%

Banking$794.5BNYSE

LLY

Eli Lilly and Co

$927.03

-6.70%

Pharmaceuticals$884.0BNYSE

60-day price, rebased to 100

JPM +1.26% · LLY -12.77%

Round-by-round

JPM 3·LLY 3

EdgeJPM

Valuation upside

-54.10% vs -92.70% to DCF fair value

EdgeLLY

Balance-sheet strength

Altman Z 0.52 vs 15.74

EdgeLLY

Fundamental quality

Piotroski 5.00 vs 6.00 (of 9)

EdgeJPM

Growth + margins

Rule-of-40 9.40 vs -9.10

EdgeJPM

60-day momentum

+1.26% vs -12.77% price return

EdgeLLY

Market-cap liquidity

$794.5B vs $884.0B

Verdict

Across 6 categories, the two names are evenly matched — 3 wins each. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on JPM or LLY

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.